查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1878156

全球维生素D市场－2025-2030年预测

Global Vitamin D Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球维生素 D 市场预计将从 2025 年的 17.67 亿美元成长到 2030 年的 23.51 亿美元，复合年增长率为 5.88%。

维生素D是一种脂溶性维生素，对维持最佳生理功能和整体健康至关重要。市面上主要有两种生物活性形式的维生素D：维生素D3（胆钙化醇），提取自鱼油、蛋黄和乳製品等动物性产品；以及维生素D2（麦角钙化醇）。维生素D3在人体对钙和磷的吸收中发挥着特别重要的作用，支持骨骼矿化和免疫系统功能等基本生理过程。商业性的维生素D3产品有多种标准化浓度，并以油基和粉剂形式供应，适用于包括成人、孕妇和儿童在内的各类消费族群。

全球维生素D市场的扩张是由多种关键因素共同推动的。消费者对维生素D营养健康益处的认知不断提高、已开发市场可支配收入的成长以及产品在各种零售和医药分销管道的广泛普及，为市场成长奠定了坚实的基础。尤其值得注意的是，消费者在预防性医疗保健方面的支出不断增加，尤其是在已开发地区，加速了维生素D补充剂的普及。政府主导的食品强化计画进一步塑造了这个市场环境，改变了膳食补充剂的市场结构。产品设计日益精细化，针对特定族群的产品不断涌现，例如孕产妇营养、老年人健康和儿童营养补充品。越来越多的科学证据支持维生素补充剂的益处，这也提振了产业信心，并推动了监管部门的核准，从而创造了有利的市场环境。

全球骨质疏鬆症盛行率的不断上升，为相关市场带来了巨大的机会。骨质疏鬆症的特征是骨骼密度降低和骨微结构劣化，增加骨折风险。此疾病在停经后妇女中特别常见，其风险因子包括遗传倾向、低体重指数（BMI）和荷尔蒙变化。维生素D在钙和磷的吸收中发挥着至关重要的作用，是维持骨骼健康和控制该族群骨质疏鬆症的基础。大量患者的需求持续旺盛，使得维生素D治疗和预防补充剂的需求量庞大。

同时，产品研发创新正成为推动市场发展的强大动力。市场扩张主要得益于先进速效维生素D製剂的推出，与传统补充剂相比，这些製剂具有更高的生物利用度和更快的疗效。这些新一代产品旨在有效纠正严重的维生素D缺乏症，并缩短患者的康復时间。领先的製造商正优先研发这些速效补充剂以抢占市场份额，因为它们已证明能更快地达到治疗所需的血液浓度，从而更快地支持诸如优化免疫功能等目标的实现。

按地区划分，亚太地区占据最大的市场份额，预计在整个预测期内将保持主导地位。该地区的成长主要得益于丰富的原料供应，尤其是乳製品产业的原料供应，以及消费者可支配收入的稳定成长。此外，该地区独特的健康挑战，例如某些国家非传染性疾病蔓延导致的高维生素D缺乏症发病率，也为治疗性和预防性维生素D产品创造了巨大的市场机会。

北美市场预计也将迎来显着成长，主要驱动力是消费者对维生素D健康益处的认知不断提高。然而，该地区也面临严峻的营养挑战，由于饮食摄取不足，维生素D缺乏症的病例屡见不鲜。这项公共卫生挑战将显着推高对维生素D补充剂和强化食品的需求，从而确保该地区市场强劲且持续成长。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
  • 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议：利用这些见解，在快速变化的环境中製定策略决策，发展新的商业机会和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

您打算如何使用这份报告？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

研究范围：

  • 2022年至2024年的历史数据和2025年至2030年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区分類的收入成长和预测评估，包括国家/地区
  • 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围

第二章 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

5. 全球维生素D市场（以类似物类型划分）

  • 介绍
  • 维生素D2
  • 维生素D3

6. 全球维生素D市场依应用领域划分

  • 介绍
  • 动物饲料和宠物食品
  • 功能性食品和饮料
  • 个人护理
  • 製药

7. 全球维生素D市场（以最终用户划分）

  • 介绍
  • 儿童
  • 成人
  • 孕妇

8. 全球维生素D市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • BASF
  • DSM
  • Fermenta Biotech Ltd.
  • Zhejiang Medicine Co., Ltd.
  • Zhejiang Garden Biochemical High-Tech Co., Ltd
  • Glanbia
  • Nestle SA
  • Pfizer, Inc.
  • Zhejiang Xinhecheng Co., Ltd
  • McKinley Resources Inc.

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061614494

The global vitamin D market is expected to grow at a 5.88% CAGR, achieving USD 2.351 billion by 2030 from USD 1.767 billion in 2025.

Vitamin D is an essential fat-soluble vitamin critical for optimal physiological function and the maintenance of overall health. The commercial market is primarily composed of two bioactive forms: vitamin D3 (cholecalciferol), which is sourced from animal-derived products such as fish oils, egg yolks, and dairy, and vitamin D2 (ergocalciferol). Vitamin D3 plays a particularly vital role in the body's absorption of calcium and phosphorus, thereby supporting fundamental processes like bone mineralization and immune system function. Commercially, vitamin D3 is formulated into standardized potencies and is available in both oil-based and powder delivery systems, targeting a diverse range of consumer segments including adults, pregnant women, and pediatric populations.

The expansion of the global vitamin D market is propelled by a confluence of key factors. Increasing consumer awareness of the nutritional health benefits associated with vitamin D, coupled with rising disposable income in developed markets and widespread product availability across various retail and pharmaceutical distribution channels, forms a strong foundation for growth. A notable trend is the enhanced consumer spending on preventive healthcare, particularly in developed regions, which has accelerated the adoption of vitamin D supplements. This environment has been further shaped by government-mandated food fortification programs, which have transformed the dietary supplement landscape. Formulations are becoming increasingly sophisticated and targeted toward specialized demographic segments, including prenatal and postnatal nutrition, geriatric health, and pediatric supplementation. The growing body of scientific evidence supporting the benefits of vitamin supplementation has also fostered positive industry sentiment and regulatory acceptance, creating a favorable market climate.

A significant and disease-driven market opportunity stems from the increasing global prevalence of osteoporosis, a condition characterized by decreased bone mineral density and compromised bone microarchitecture that leads to a higher risk of fractures. This condition is particularly prevalent among post-menopausal women, with risk factors including genetic predisposition, low body mass index, and hormonal changes. Given vitamin D's essential role in calcium and phosphorus absorption, it is a cornerstone for maintaining bone health and managing osteoporosis in this demographic. The substantial number of individuals affected by this condition creates a persistent and substantial demand for vitamin D therapeutics and preventive supplements.

Concurrently, innovation in product development is acting as a powerful market catalyst. The introduction of advanced, fast-acting vitamin D formulations is driving market expansion by offering improved bioavailability and a faster therapeutic response compared to conventional supplements. These next-generation products are designed to effectively address severe vitamin D deficiencies and accelerate patient recovery timelines. Leading manufacturers are prioritizing the development of these rapid-absorption supplements to capture market share, with such innovations demonstrating significantly faster efficacy in achieving therapeutic serum levels, thereby supporting goals like immune function optimization more rapidly.

From a geographical perspective, the Asia Pacific region maintains the largest market revenue share and is projected to sustain this leadership position throughout the forecast period. Regional growth is underpinned by abundant raw material availability, particularly from the dairy sector, and consistently rising consumer disposable income. Furthermore, specific regional health challenges, such as higher rates of vitamin D deficiency linked to the prevalence of non-communicable diseases in certain countries, create significant market opportunities for both therapeutic and preventive vitamin D products.

The North American market is also anticipated to experience substantial growth, largely driven by increased consumer awareness of the health benefits of vitamin D. However, the region concurrently faces significant nutritional challenges, with widespread vitamin D deficiency reported due to inadequate dietary intake. This public health issue presents a clear demand driver for supplementation and fortified food products, ensuring a dynamic and growing market in the region.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

  • GLOBAL VITAMIN D MARKET BY ANALOG TYPE
  • Vitamin D2
  • Vitamin D3
  • GLOBAL VITAMIN D MARKET BY APPLICATION
  • Animal feed & pet food
  • Functional food & beverages
  • Personal care
  • Pharmaceuticals
  • GLOBAL VITAMIN D MARKET BY END-USER
  • Children
  • Adults
  • Pregnant Women
  • GLOBAL VITAMIN D MARKET BY GEOGRAPHY
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL VITAMIN D MARKET BY ANALOG TYPE

  • 5.1. Introduction
  • 5.2. Vitamin D2
  • 5.3. Vitamin D3

6. GLOBAL VITAMIN D MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Animal feed & pet food
  • 6.3. Functional food & beverages
  • 6.4. Personal care
  • 6.5. Pharmaceuticals

7. GLOBAL VITAMIN D MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Children
  • 7.3. Adults
  • 7.4. Pregnant Women

8. GLOBAL VITAMIN D MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. BASF
  • 10.2. DSM
  • 10.3. Fermenta Biotech Ltd.
  • 10.4. Zhejiang Medicine Co., Ltd.
  • 10.5. Zhejiang Garden Biochemical High-Tech Co., Ltd
  • 10.6. Glanbia
  • 10.7. Nestle SA
  • 10.8. Pfizer, Inc.
  • 10.9. Zhejiang Xinhecheng Co., Ltd
  • 10.10. McKinley Resources Inc.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations